首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1532513

乳膠凝集測試套件市場，按測試類型（抗體檢測、抗原測試）、感染類型（鏈球菌、葡萄球菌、埃希氏菌、沙門氏菌）、樣本類型（血液、尿液、腦脊髓液）、最終用途- 全球預測2024 - 2032

Latex Agglutination Test Kits Market, By Test Type (Antibody Detection, Antigen Testing), Infection Type (Streptococcus, Staphylococcus, Escherichia, Salmonella), Sample Type (Blood, Urine, Cerebrospinal Fluid), End-use - Global Forecast 2024 - 2032

出版日期: 2024年05月21日 | 出版商:

Global Market Insights Inc. | 英文 231 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在傳染病日益普及的推動下，2024 年至 2032 年全球乳膠凝集測試套件市場複合年成長率將超過 6.5%。根據世界衛生組織2023年報告顯示，2019年至2023年，全球結核病等傳染病病例增加了10%，2023年新增病例約1,060萬例。

隨著全球傳染病發病率的上升，越來越需要有效、可靠的診斷工具來及時檢測和管理它們。乳膠凝集測試能夠提供快速、準確的結果，這使得它們在對抗傳染病爆發方面至關重要。對診斷準確性的更高需求導致了診斷技術的創新和更多產品的採用，從而加速了市場成長。

乳膠凝集測試套件市場根據測試類型、感染類型、樣本類型、最終用途和地區進行分類。

到 2032 年，抗體檢測領域將呈現出顯著的複合年成長率，因其能夠提供快速、精確且具成本效益的結果。這些測試對於識別和量化特異性抗體非常重要，這對於診斷和監測各種疾病至關重要。隨著醫療保健提供者越來越關注個人化醫療和早期疾病檢測，對高效抗體檢測工具的需求激增。此外，對預防性醫療保健和常規篩檢的日益重視，也導致人們對用於抗體檢測的乳膠凝集檢測試劑盒的興趣日益濃厚。

由於人們越來越擔心葡萄球菌的抗生素抗藥性菌株，到 2032 年，葡萄球菌細分市場將佔據相當大的市場佔有率。金黃色葡萄球菌，特別是抗甲氧西林金黃色葡萄球菌 MRSA，給治療帶來了巨大的挑戰，因此準確、快速的檢測對於有效的治療至關重要。醫療機構正在優先考慮能夠快速識別這些感染的工具，以確保及時介入和適當的治療。這將推動對專門用於檢測金黃色葡萄球菌感染的專用檢測試劑盒的需求。

由於醫療基礎設施投資的增加和診斷技術的進步，北美乳膠凝集測試套件市場在預測期內將出現顯著的複合年成長率。對早期疾病檢測和個人化醫療的高度重視刺激了對準確、快速診斷工具的需求。此外，人們對感染控制和預防性醫療措施的認知不斷提高，也導致了產品需求的成長。醫療保健產業著重採用創新、高效的診斷解決方案，這有利於研究經費和技術進步，從而推動該地區的市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 傳染病和自體免疫疾病盛行率上升
  - 對即時檢測 (POCT) 的需求不斷增加
  - 技術創新
  - 提高認知和篩檢計劃
- 產業陷阱與挑戰
  - 嚴格的監管要求
成長潛力分析
技術景觀
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按測試類型，2021 - 2032 年

主要趨勢
抗體檢測
抗原檢測

第 6 章：市場估計與預測：按感染類型，2021 - 2032

主要趨勢
鏈球菌屬
金黃色葡萄球菌
大腸桿菌
沙門氏菌屬
其他感染類型

第 7 章：市場估計與預測：按樣本類型，2021 - 2032

主要趨勢
血
尿
腦脊髓液
其他樣品類型

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診斷實驗室
學術及研究機構

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Atlas Medical GmbH
Arlington Scientific, Inc
Bio-Rad Laboratories, Inc.
bioMerieuxSA
Biotium
Creative Diagnostics
Cardinal Health, Inc.
Eurofins Scientific Group
Hardy plc
HiMedia Laboratories
Liofilchem S.r.l.
Novacyt Group
PerkinElmer, Inc.
Pro Lab Diagnostics
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9570

Global Latex Agglutination Test Kits Market will experience over 6.5% CAGR from 2024 to 2032, thrusted by the growing prevalence of infectious diseases. According to the WHO reports in 2023, global cases of infectious diseases such as tuberculosis TB increased by 10% from 2019 to 2023, reaching approximately 10.6 million new cases in 2023.

As the incidence rate of infectious ailment rises globally, there is an increasing need for effective and reliable diagnostic tools to detect and manage them promptly. The ability of latex agglutination tests to deliver rapid and accurate results makes them crucial in the fight against infectious outbreaks. This heightened demand for diagnostic accuracy leads to innovation in diagnostic technology and greater product adoption, accelerating market growth.

The latex agglutination test kits market is categorized based on test type, infection type, sample type, end-use, and region.

The antibody detection segment will exhibit a noticeable CAGR through 2032, catapulted by its ability to offer quick, precise, and cost-effective results. These tests are important for identifying and quantifying specific antibodies, which is crucial in diagnosing and monitoring various diseases. As healthcare providers increasingly focus on personalized medicine and early disease detection, the need for efficient antibody detection tools has surged. Additionally, the growing emphasis on preventive healthcare and routine screening contributes to the heightened interest in latex agglutination test kits for antibody detection.

The staphylococcus segment will grab a substantial market share by 2032, owing to the growing concern over antibiotic-resistant strains of this bacterium. Staphylococcus aureus, particularly methicillin-resistant Staphylococcus aureus MRSA, poses significant treatment challenges, making accurate and rapid detection essential for effective management. Healthcare settings are prioritizing tools that swiftly identify these infections to ensure timely intervention and appropriate treatment. This will drive the demand for specialized test kits tailored to detect Staphylococcus aureus infections.

North America latex agglutination test kits market will register a prominent CAGR during the forecast period, because of increased investment in healthcare infrastructure and advancements in diagnostic technology. The strong emphasis on early disease detection and personalized medicine spurs the need for accurate and rapid diagnostic tools. Additionally, heightened awareness of infection control and preventive healthcare measures contributes to the rising product demand. The focus in healthcare sector on adopting innovative and efficient diagnostic solutions is favoring research funding and technological advancements, thereby propelling the market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of infectious and autoimmune diseases
  - 3.2.1.2 Increasing demand for point-of-care testing (POCT)
  - 3.2.1.3 Technological innovations
  - 3.2.1.4 Increasing awareness and screening programs
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Antibody detection
5.3 Antigen testing

Chapter 6 Market Estimates and Forecast, By Infection Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Streptococcus
6.3 Staphylococcus Aureus
6.4 Escherichia Coli
6.5 Salmonella Spp.
6.6 Other infection types

Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Blood
7.3 Urine
7.4 Cerebrospinal fluid
7.5 Other sample types

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa